The $5 Biotech Stock Sitting On A New Patent... for What???

I'm going to cut straight to the chase. I'm going to cut straight to the chase. Energy and Capital: Practical Investment Analysis in the new Energy Economy [Energy and Capital logo] The $5 Biotech Stock Sitting On A New Patent... for What??? By Keith Kohl | March 24, 2022 - Baltimore, MD I'm going to cut straight to the chase. I believe within the next few months we are going to see medical technology advance in America at an unprecedented pace. Not only will the technology we use on a day-to-day basis drastically change... But it will also render current medical practices entirely obsolete. Honestly, when you read what I’ve written up [in this special report...]( You probably won’t believe it. When I first discovered it, I sure didn't — it sounds like something out of a science-fiction novel! But I’m going to show you exactly why I think we're on the cusp of this revolution... And how [this patent]( and the company behind it are going to play a crucial role. I have NEVER seen technology like this in my lifetime. NONE of my colleagues have either... Which is why right now, as the company behind this patent trades for less than $5, is the perfect time to get into position. McKinsey reports that this technology could unlock a whopping $4 trillion market. And I’m convinced that because of this groundbreaking new technology, this tiny Maryland-based company could be at the forefront of this medical revolution. [Read my full report here.]( To your wealth, [Keith's sign off] Keith Kohl Investment Director, Topline Trader P.S. This isn’t just a medical breakthrough — it’s a revolutionary TECHNOLOGY breakthrough that could plant America firmly in the future. I expect massive growth in this industry in the coming months, but it could explode any day now. Please take the time to read at least the beginning of this special report. --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](